Gynecological Cancer Diagnostics Market, Global Outlook and Forecast 2022-2028

April 2022 | 69 pages | ID: G0BD4025A9F0EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Gynecological Cancer Diagnostics in Global, including the following market information:

Global Gynecological Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gynecological Cancer Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Genetic Counseling Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gynecological Cancer Diagnostics include UT Southwestern, Abramson Cancer Center, Northwestern Medicine, Sysmex Europe SE, Fujirebio, Premier Health, Agilent Technologies, Inc, ARUP Laboratories and CENTOGENE, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gynecological Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gynecological Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gynecological Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)

• Genetic Counseling Test
• Cancer Risk Test
• Kits Test

Global Gynecological Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gynecological Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Gestational Trophoblastic Disease Diagnostics
• Endometrial Cancer Diagnostics
• Peritoneal Cancer Diagnostics
• Cervical Cancer Diagnostics
• Ovarian Cancer Diagnostics
• Vaginal Cancer Diagnostics
• Uterine Cancer Diagnostics
• Vulvar Cancer Diagnostics

Global Gynecological Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gynecological Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gynecological Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gynecological Cancer Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• UT Southwestern
• Abramson Cancer Center
• Northwestern Medicine
• Sysmex Europe SE
• Fujirebio
• Premier Health
• Agilent Technologies, Inc
• ARUP Laboratories
• CENTOGENE
• F. Hoffmann-La Roche Ltd
• Fulgent Genetics, Inc
• Invitae Corporation
• Myriad Genetics, Inc
• BGI Group

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gynecological Cancer Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gynecological Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GYNECOLOGICAL CANCER DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Gynecological Cancer Diagnostics Market Size: 2021 VS 2028
2.2 Global Gynecological Cancer Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gynecological Cancer Diagnostics Players in Global Market
3.2 Top Global Gynecological Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Gynecological Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Gynecological Cancer Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gynecological Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gynecological Cancer Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Gynecological Cancer Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gynecological Cancer Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gynecological Cancer Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 Genetic Counseling Test
  4.1.3 Cancer Risk Test
  4.1.4 Kits Test
4.2 By Type - Global Gynecological Cancer Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Gynecological Cancer Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global Gynecological Cancer Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global Gynecological Cancer Diagnostics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gynecological Cancer Diagnostics Market Size, 2021 & 2028
  5.1.2 Gestational Trophoblastic Disease Diagnostics
  5.1.3 Endometrial Cancer Diagnostics
  5.1.4 Peritoneal Cancer Diagnostics
  5.1.5 Cervical Cancer Diagnostics
  5.1.6 Ovarian Cancer Diagnostics
  5.1.7 Vaginal Cancer Diagnostics
  5.1.8 Uterine Cancer Diagnostics
  5.1.9 Vulvar Cancer Diagnostics
5.2 By Application - Global Gynecological Cancer Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Gynecological Cancer Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global Gynecological Cancer Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global Gynecological Cancer Diagnostics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gynecological Cancer Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Gynecological Cancer Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Gynecological Cancer Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global Gynecological Cancer Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global Gynecological Cancer Diagnostics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gynecological Cancer Diagnostics Revenue, 2017-2028
  6.3.2 US Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.3.3 Canada Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.3.4 Mexico Gynecological Cancer Diagnostics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gynecological Cancer Diagnostics Revenue, 2017-2028
  6.4.2 Germany Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.4.3 France Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.4.4 U.K. Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.4.5 Italy Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.4.6 Russia Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.4.7 Nordic Countries Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.4.8 Benelux Gynecological Cancer Diagnostics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gynecological Cancer Diagnostics Revenue, 2017-2028
  6.5.2 China Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.5.3 Japan Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.5.4 South Korea Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.5.5 Southeast Asia Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.5.6 India Gynecological Cancer Diagnostics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gynecological Cancer Diagnostics Revenue, 2017-2028
  6.6.2 Brazil Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.6.3 Argentina Gynecological Cancer Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gynecological Cancer Diagnostics Revenue, 2017-2028
  6.7.2 Turkey Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.7.3 Israel Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.7.4 Saudi Arabia Gynecological Cancer Diagnostics Market Size, 2017-2028
  6.7.5 UAE Gynecological Cancer Diagnostics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 UT Southwestern
  7.1.1 UT Southwestern Corporate Summary
  7.1.2 UT Southwestern Business Overview
  7.1.3 UT Southwestern Gynecological Cancer Diagnostics Major Product Offerings
  7.1.4 UT Southwestern Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.1.5 UT Southwestern Key News
7.2 Abramson Cancer Center
  7.2.1 Abramson Cancer Center Corporate Summary
  7.2.2 Abramson Cancer Center Business Overview
  7.2.3 Abramson Cancer Center Gynecological Cancer Diagnostics Major Product Offerings
  7.2.4 Abramson Cancer Center Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.2.5 Abramson Cancer Center Key News
7.3 Northwestern Medicine
  7.3.1 Northwestern Medicine Corporate Summary
  7.3.2 Northwestern Medicine Business Overview
  7.3.3 Northwestern Medicine Gynecological Cancer Diagnostics Major Product Offerings
  7.3.4 Northwestern Medicine Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.3.5 Northwestern Medicine Key News
7.4 Sysmex Europe SE
  7.4.1 Sysmex Europe SE Corporate Summary
  7.4.2 Sysmex Europe SE Business Overview
  7.4.3 Sysmex Europe SE Gynecological Cancer Diagnostics Major Product Offerings
  7.4.4 Sysmex Europe SE Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.4.5 Sysmex Europe SE Key News
7.5 Fujirebio
  7.5.1 Fujirebio Corporate Summary
  7.5.2 Fujirebio Business Overview
  7.5.3 Fujirebio Gynecological Cancer Diagnostics Major Product Offerings
  7.5.4 Fujirebio Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.5.5 Fujirebio Key News
7.6 Premier Health
  7.6.1 Premier Health Corporate Summary
  7.6.2 Premier Health Business Overview
  7.6.3 Premier Health Gynecological Cancer Diagnostics Major Product Offerings
  7.6.4 Premier Health Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.6.5 Premier Health Key News
7.7 Agilent Technologies, Inc
  7.7.1 Agilent Technologies, Inc Corporate Summary
  7.7.2 Agilent Technologies, Inc Business Overview
  7.7.3 Agilent Technologies, Inc Gynecological Cancer Diagnostics Major Product Offerings
  7.7.4 Agilent Technologies, Inc Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.7.5 Agilent Technologies, Inc Key News
7.8 ARUP Laboratories
  7.8.1 ARUP Laboratories Corporate Summary
  7.8.2 ARUP Laboratories Business Overview
  7.8.3 ARUP Laboratories Gynecological Cancer Diagnostics Major Product Offerings
  7.8.4 ARUP Laboratories Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.8.5 ARUP Laboratories Key News
7.9 CENTOGENE
  7.9.1 CENTOGENE Corporate Summary
  7.9.2 CENTOGENE Business Overview
  7.9.3 CENTOGENE Gynecological Cancer Diagnostics Major Product Offerings
  7.9.4 CENTOGENE Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.9.5 CENTOGENE Key News
7.10 F. Hoffmann-La Roche Ltd
  7.10.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.10.2 F. Hoffmann-La Roche Ltd Business Overview
  7.10.3 F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Major Product Offerings
  7.10.4 F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.10.5 F. Hoffmann-La Roche Ltd Key News
7.11 Fulgent Genetics, Inc
  7.11.1 Fulgent Genetics, Inc Corporate Summary
  7.11.2 Fulgent Genetics, Inc Business Overview
  7.11.3 Fulgent Genetics, Inc Gynecological Cancer Diagnostics Major Product Offerings
  7.11.4 Fulgent Genetics, Inc Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.11.5 Fulgent Genetics, Inc Key News
7.12 Invitae Corporation
  7.12.1 Invitae Corporation Corporate Summary
  7.12.2 Invitae Corporation Business Overview
  7.12.3 Invitae Corporation Gynecological Cancer Diagnostics Major Product Offerings
  7.12.4 Invitae Corporation Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.12.5 Invitae Corporation Key News
7.13 Myriad Genetics, Inc
  7.13.1 Myriad Genetics, Inc Corporate Summary
  7.13.2 Myriad Genetics, Inc Business Overview
  7.13.3 Myriad Genetics, Inc Gynecological Cancer Diagnostics Major Product Offerings
  7.13.4 Myriad Genetics, Inc Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.13.5 Myriad Genetics, Inc Key News
7.14 BGI Group
  7.14.1 BGI Group Corporate Summary
  7.14.2 BGI Group Business Overview
  7.14.3 BGI Group Gynecological Cancer Diagnostics Major Product Offerings
  7.14.4 BGI Group Gynecological Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.14.5 BGI Group Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gynecological Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Gynecological Cancer Diagnostics Market Drivers in Global Market
Table 3. Gynecological Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Gynecological Cancer Diagnostics in Global Market
Table 5. Top Gynecological Cancer Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gynecological Cancer Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gynecological Cancer Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gynecological Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Gynecological Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gynecological Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gynecological Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gynecological Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gynecological Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gynecological Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gynecological Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gynecological Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. UT Southwestern Corporate Summary
Table 31. UT Southwestern Gynecological Cancer Diagnostics Product Offerings
Table 32. UT Southwestern Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Abramson Cancer Center Corporate Summary
Table 34. Abramson Cancer Center Gynecological Cancer Diagnostics Product Offerings
Table 35. Abramson Cancer Center Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Northwestern Medicine Corporate Summary
Table 37. Northwestern Medicine Gynecological Cancer Diagnostics Product Offerings
Table 38. Northwestern Medicine Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Sysmex Europe SE Corporate Summary
Table 40. Sysmex Europe SE Gynecological Cancer Diagnostics Product Offerings
Table 41. Sysmex Europe SE Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Fujirebio Corporate Summary
Table 43. Fujirebio Gynecological Cancer Diagnostics Product Offerings
Table 44. Fujirebio Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Premier Health Corporate Summary
Table 46. Premier Health Gynecological Cancer Diagnostics Product Offerings
Table 47. Premier Health Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Agilent Technologies, Inc Corporate Summary
Table 49. Agilent Technologies, Inc Gynecological Cancer Diagnostics Product Offerings
Table 50. Agilent Technologies, Inc Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. ARUP Laboratories Corporate Summary
Table 52. ARUP Laboratories Gynecological Cancer Diagnostics Product Offerings
Table 53. ARUP Laboratories Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. CENTOGENE Corporate Summary
Table 55. CENTOGENE Gynecological Cancer Diagnostics Product Offerings
Table 56. CENTOGENE Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. F. Hoffmann-La Roche Ltd Corporate Summary
Table 58. F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Product Offerings
Table 59. F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. Fulgent Genetics, Inc Corporate Summary
Table 61. Fulgent Genetics, Inc Gynecological Cancer Diagnostics Product Offerings
Table 62. Fulgent Genetics, Inc Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. Invitae Corporation Corporate Summary
Table 64. Invitae Corporation Gynecological Cancer Diagnostics Product Offerings
Table 65. Invitae Corporation Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 66. Myriad Genetics, Inc Corporate Summary
Table 67. Myriad Genetics, Inc Gynecological Cancer Diagnostics Product Offerings
Table 68. Myriad Genetics, Inc Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 69. BGI Group Corporate Summary
Table 70. BGI Group Gynecological Cancer Diagnostics Product Offerings
Table 71. BGI Group Gynecological Cancer Diagnostics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Gynecological Cancer Diagnostics Segment by Type in 2021
Figure 2. Gynecological Cancer Diagnostics Segment by Application in 2021
Figure 3. Global Gynecological Cancer Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gynecological Cancer Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gynecological Cancer Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gynecological Cancer Diagnostics Revenue in 2021
Figure 8. By Type - Global Gynecological Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gynecological Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gynecological Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gynecological Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gynecological Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gynecological Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gynecological Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gynecological Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gynecological Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. UT Southwestern Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abramson Cancer Center Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Northwestern Medicine Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sysmex Europe SE Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Fujirebio Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Premier Health Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Agilent Technologies, Inc Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. ARUP Laboratories Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. CENTOGENE Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Fulgent Genetics, Inc Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Invitae Corporation Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Myriad Genetics, Inc Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. BGI Group Gynecological Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)